VIPR1 antibody (C-Term)

Catalog No. ABIN3043057

Product Details anti-VIPR1 Antibody

Target: VIPR1 (Vasoactive Intestinal Peptide Receptor 1 (VIPR1))

Binding Specificity: AA 400-414, C-Term

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This VIPR1 antibody is un-conjugated

Application: Western Blotting (WB)

Purpose: Rabbit IgG polyclonal antibody for Vasoactive intestinal polypeptide receptor 1(VIPR1) detection. Tested with WB in Human,Mouse,Rat.

Sequence: RRKWRRWHLQ GVLGW

Cross-Reactivity (Details): Predicted Cross Reactivity: mouse, rat
No cross reactivity with other proteins.
Predicted Cross Reactivity: Species predicted to be fit for the product based on sequence similarities.

Characteristics: Rabbit IgG polyclonal antibody for Vasoactive intestinal polypeptide receptor 1(VIPR1) detection. Tested with WB in Human,Mouse,Rat.
Gene Name: vasoactive intestinal peptide receptor 1
Protein Name: Vasoactive intestinal polypeptide receptor 1(VIP-R-1)

Purification: Immunogen affinity purified.

Immunogen: A synthetic peptide corresponding to a sequence at the C-terminus of human VIP Receptor 1(400-414aa RRKWRRWHLQGVLGW), identical to the related rat and mouse sequences.

Isotype: IgG

Application Details

Application Notes: WB: Concentration: 0.1-0.5 μg/mL, Tested Species: Human, Predicted Species: Mouse, Rat
Notes: Tested Species: Species with positive results. Predicted Species: Species predicted to be fit for the product based on sequence similarities.
Other applications have not been tested. Optimal dilutions should be determined by end users.

Comment:

Antibody can be supported by chemiluminescence kit ABIN921124 in WB.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.

Concentration: 500 μg/mL

Buffer: Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Thimerosal, 0.05 mg Sodium azide.

Preservative: Thimerosal (Merthiolate), Sodium azide

Precaution of Use: This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.

Handling Advice: Avoid repeated freezing and thawing.

Storage: 4 °C/-20 °C

Storage Comment: At -20°C for one year. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20 °C for a longer time. Avoid repeated freezing and thawing.

Expiry Date: 12 months

Target Details for VIPR1

Target: VIPR1 (Vasoactive Intestinal Peptide Receptor 1 (VIPR1))

Alternative Name: VIPR1 (VIPR1 Products)

Synonyms: HVR1 antibody, II antibody, PACAP-R-2 antibody, PACAP-R2 antibody, RDC1 antibody, V1RG antibody, VAPC1 antibody, VIP-R-1 antibody, VIPR antibody, VIRG antibody, VPAC1 antibody, VPAC1R antibody, VPCAP1R antibody, CVIPR antibody, AV071699 antibody, VIP-R1 antibody, RATVASREC antibody, VASREC antibody, VIPR1 antibody, LOC100226500 antibody, vipr1 antibody, hvr1 antibody, rdc1 antibody, v1rg antibody, vipr antibody, virg antibody, vapc1 antibody, vpac1 antibody, vpcap1 antibody, vpac1-r antibody, VIP-R antibody, vasoactive intestinal peptide receptor 1 antibody, vasoactive intestinal peptide receptor 1b antibody, vasoactive intestinal peptide receptor 1 S homeolog antibody, vasoactive intestinal polypeptide receptor antibody, VIPR1 antibody, Vipr1 antibody, vipr1b antibody, vipr1 antibody, vipr1.S antibody, LOC100303683 antibody

Background: VIPR1(Vasoactive intestinal polypeptide receptor 1), also known as VIPR,HVR1, is a protein that in humans is encoded by the VIPR1 gene. Distinct subsets of neural, respiratory, gastrointestinal, and immune cells bear specific high-affinity G protein-coupled receptors for VIP, such as VIPR1. The VIPR1 gene is mapped on 3p22.1. The VIPR1 gene was found to span approximately 22 kb and to be comprised of 13 exons(ranging from 42 to 1,400 bp) and 12 introns(ranging from 0.3 to 6.1 kb). One encodes a VIP receptor consisting of 460 amino acids and having 7 putative transmembrane domains, as do other G protein-coupled receptors. Patients with idiopathic achalasia show a significant difference in the distribution of SNPs affecting VIPR1.

Synonyms: FLJ41949 antibody|HVR 1 antibody|HVR1 antibody|PACAP R 2 antibody|PACAP type II receptor antibody|PACAP-R-2 antibody|PACAP-R2 antibody|Pituitary adenylate cyclase activating polypeptide receptor type II antibody|Pituitary adenylate cyclase activating polypeptide type II receptor antibody|Pituitary adenylate cyclase-activating polypeptide type II receptor antibody|RCD1 antibody|RDC 1 antibody|RDC1 antibody|V1RG antibody|VAPC 1 antibody|VAPC1 antibody|Vasoactive intestinal peptide receptor 1 antibody|Vasoactive intestinal polypeptide receptor 1 antibody|Vasoactive intestinal polypeptide receptor 1 precursor antibody|VIP R 1 antibody|VIP receptor type I antibody|VIP-R-1 antibody|VIPR 1 antibody|VIPR antibody|VIPR1 antibody|VIPR1_HUMAN antibody|VIRG antibody|VPAC 1 antibody|VPAC1 antibody|VPCAP1R antibody

UniProt: P32241